Literature DB >> 12928860

Host and parasite apoptosis following Trypanosoma cruzi infection in in vitro and in vivo models.

E M de Souza1, T C Araújo-Jorge, C Bailly, A Lansiaux, M M Batista, G M Oliveira, M N C Soeiro.   

Abstract

The mechanism of cell death which occurs during Chagas' cardiopathy is disputed. To address this issue we analyzed the molecular pathways implicated in the death of cardiomyocytes during T. cruzi invasion and found that they undergo apoptosis during both in vitro and in vivo infections. However, the death rates and onset were related to the parasite stocks belonging to different biodemes, which can be correlated to the different histological inflammation findings that have already been reported. Our in vitro data provide additional support for this hypothesis since higher levels and earlier apoptosis induction were noted during the interaction with the Dm28c (type I) as compared to the Y and CL stocks (type II). Modifications of the surface carbohydrates of the infected cardiomyocytes were observed and these molecular events may be acting as "eat me" tags for their final engulfment by macrophages and/or other non-professional phagocytes. The analysis of other host cell types showed that the in vitro infection of fibroblasts did not result in host apoptosis even when a highly infective stock was used. Conversely, infected macrophages undergo apoptosis but at a higher degree than cardiomyocytes. Apoptotic intracellular parasites were observed to varied extents depending on the T. cruzi stock, which was related to the parasite invasion and proliferation. In summary, our results show that during T. cruzi infection, the extent of apoptosis varies according to the host cell type and the parasite stocks. The apoptosis of both host and T. cruzi can contribute to the silent spreading and persistence of the parasite without triggering an exacerbated inflammatory response.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12928860     DOI: 10.1007/s00441-003-0782-5

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  23 in total

1.  Oxidative stress fuels Trypanosoma cruzi infection in mice.

Authors:  Claudia N Paiva; Daniel F Feijó; Fabianno F Dutra; Vitor C Carneiro; Guilherme B Freitas; Letícia S Alves; Jacilene Mesquita; Guilherme B Fortes; Rodrigo T Figueiredo; Heitor S P Souza; Marcelo R Fantappié; Joseli Lannes-Vieira; Marcelo T Bozza
Journal:  J Clin Invest       Date:  2012-06-25       Impact factor: 14.808

2.  Interaction of natural killer cells with Trypanosoma cruzi-infected fibroblasts.

Authors:  T Lieke; C Steeg; S E B Graefe; B Fleischer; T Jacobs
Journal:  Clin Exp Immunol       Date:  2006-08       Impact factor: 4.330

3.  Fas ligand-dependent inflammatory regulation in acute myocarditis induced by Trypanosoma cruzi infection.

Authors:  Gabriel Melo de Oliveira; Rafaela Lopes Diniz; Wanderson Batista; Marcelo Meuser Batista; Cristiane Bani Correa; Tânia Cremonini de Araújo-Jorge; Andréa Henriques-Pons
Journal:  Am J Pathol       Date:  2007-07       Impact factor: 4.307

4.  Trypanosoma cruzi infection induces a global host cell response in cardiomyocytes.

Authors:  Patricio A Manque; Christian M Probst; Christian Probst; Mirian C S Pereira; Rita C P Rampazzo; Luiz Shozo Ozaki; L Shozo Ozaki; Daniela P Pavoni; Dayse T Silva Neto; M Ruth Carvalho; Ping Xu; Myrna G Serrano; João M P Alves; Maria de Nazareth S L Meirelles; Samuel Goldenberg; Marco A Krieger; Gregory A Buck
Journal:  Infect Immun       Date:  2011-02-22       Impact factor: 3.441

5.  Dependence on p38 MAPK signalling in the up-regulation of TLR2, TLR4 and TLR9 gene expression in Trichomonas vaginalis-treated HeLa cells.

Authors:  Jae-Ho Chang; Ju-Youn Park; Soo-Ki Kim
Journal:  Immunology       Date:  2006-06       Impact factor: 7.397

6.  Identification of Anti-Trypanosoma cruzi Lead Compounds with Putative Immunomodulatory Activity.

Authors:  Dayane Andriotti Otta; Fernanda Fortes de Araújo; Vitor Bortolo de Rezende; Elaine Maria Souza-Fagundes; Silvana Maria Elói-Santos; Matheus Fernandes Costa-Silva; Raiany Araújo Santos; Heloísa Alves Costa; Jair Lage Siqueira-Neto; Olindo Assis Martins-Filho; Andréa Teixeira-Carvalho
Journal:  Antimicrob Agents Chemother       Date:  2018-03-27       Impact factor: 5.191

Review 7.  Trypanosoma cruzi antioxidant enzymes as virulence factors in Chagas disease.

Authors:  Lucía Piacenza; Gonzalo Peluffo; María Noel Alvarez; Alejandra Martínez; Rafael Radi
Journal:  Antioxid Redox Signal       Date:  2012-05-21       Impact factor: 8.401

8.  Challenge of chronically infected mice with homologous trypanosoma cruzi parasites enhances the immune response but does not modify cardiopathy: implications for the design of a therapeutic vaccine.

Authors:  Christian Emerson Rosas-Jorquera; Luiz Roberto Sardinha; Fernando Delgado Pretel; André Luis Bombeiro; Maria Regina D'Império Lima; José Maria Alvarez
Journal:  Clin Vaccine Immunol       Date:  2012-12-19

9.  Apoptosis induced by parasitic diseases.

Authors:  Anne-Lise Bienvenu; Elena Gonzalez-Rey; Stephane Picot
Journal:  Parasit Vectors       Date:  2010-11-17       Impact factor: 3.876

Review 10.  Trypanosoma cruzi parasites fight for control of the JAK-STAT pathway by disarming their host.

Authors:  Philipp Stahl; Ralph T Schwarz; Françoise Debierre-Grockiego; Thomas Meyer
Journal:  JAKSTAT       Date:  2015-02-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.